![]() |
![]() |
(+)-(4S)-4,11-Diethyl-4-hydroxy-9--1H-pyranoindolizinoquinoline-3,14-(4H,12H)-dione hydrochloride trihydrate (1,4’-bipiperidine)-1’-carboxylicacid,4,11-diethyl-3,4,12,14-tetrahydro-4-hyd (4S)-4,11-Diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate hydrochloride trihydrate [1,4'-Bipiperidine]-1'-carboxylic acid, (4S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl ester, hydrochloride, hydrate (1:1:3) CPT-11 Trihydrate Irinotecan (hydrochloride trihydrate) Irinotecan HCL 3H2O IRINOTECAN HCL TRIHYDRATE IRINOTECAN MONOHYDROCHLORIDE TRIHYDRATE MFCD01765731 roxy-3,14-dioxo-1h-pyrano(3’,4’:6,7)indolizino(1,2-b)quinolin-9-ylester,mono trihydrate,(s)-hydrochlorid
A poison by intravenous route. Moderately toxic by ingestion. When heated to decomposition it emits toxic vapors of NOx, HCl, and Cl?.
?Irinotecan hydrochloride trihydrate , its cas register number is 136572-09-3. It also can be called (S)-[1,4'-Bipiperidine]-1'-carboxylic acid 4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl ester hydrochloride trihydrate ;?Irinotecan hydrochloride [USAN:JAN]?; (+)-7-Ethyl-10-hydroxycamptothecine 10-(1,4'-bipiperidine)-1'-carboxylate, monohydrochloride, trihydrate ; Camptosar?; Irinotecan HCl ; (1,4'-Bipiperidine)-1'-carboxylic acid, 4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinolin-9-yl ester, monohydrochloride, trihydrate, (S)- .
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LD50 | intravenous | 40mg/kg (40mg/kg) | ? | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 26, Pg. 953, 1995. |
mouse | LD50 | intravenous | 132mg/kg (132mg/kg) | ? | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 26, Pg. 953, 1995. |
mouse | LD50 | oral | 1045mg/kg (1045mg/kg) | ? | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 26, Pg. 953, 1995. |
rat | LD50 | intravenous | 83600ug/kg (83.6mg/kg) | ? | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 26, Pg. 953, 1995. |
rat | LD50 | oral | 867mg/kg (867mg/kg) | ? | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 26, Pg. 953, 1995. |
Acute toxicity - Oral, Category 4
Reproductive toxicity, Category 1B
Pictogram(s) | ![]() ![]() |
---|---|
Signal word | Danger |
Hazard statement(s) | H302 Harmful if swallowed H360 May damage fertility or the unborn child |
Precautionary statement(s) | |
Prevention | P264 Wash ... thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P280 Wear protective gloves/protective clothing/eye protection/face protection. |
Response | P301+P312 IF SWALLOWED: Call a POISON CENTER/doctor/\u2026if you feel unwell. P330 Rinse mouth. P308+P313 IF exposed or concerned: Get medical advice/ attention. |
Storage | P405 Store locked up. |
Disposal | P501 Dispose of contents/container to ... |
none